Gynecological Line:

Clinical Line:

Pediatric Line:


Gynecological Line

linfol® Cicatrizant

Regenerates vaginal epithelium with polyvalent antimicrobial protection

Repairs cervical-vulvovaginitis injuries and erosions


Full cicatrisation in: Cervix ulcers Cervical ectopias Cervicitis Post-episiotomies Vaginitis post-electrocoagulation separar


Patient information

Each vaginal ovuli contains:
Metronidazole 300 mg, Centella Asiatica 15 mg, Miconazole Nitrate 100 mg, Neomycin Sulfate 48,8 mg, Polymyxin Sulfate 4.4 mg. Excipients: c.s.

Therapeutical Action :
Therapeutical action:
LINFOL ® CICATRIZANT contains an association of active principles with antimycotic and anti-infective action for the treatment of gynecological affections. Also contains Centella asiatica, with regenerative and repairing action over the vaginal epithelium.

Indications: Local treatment of vulvovaginal mycosis, vaginitis caused by Trichomonas and non-specific vaginitis in which over-infection with neomycin and polymyxin-sensitive germs is suspected.
Contraindications: Known hypersensibility to any component of the product or to imidazole derivatives. The first three months of pregnancy. Breastfeeding. Patients with blood dyscrasias. Active Central Nervous System diseases. Severe hepatic failure.

Treatment should start with 1 to 2 vaginal ovuli introduced deeply into the vagina for 6 to 12 consecutive days. If treatment has to be repeated, a 4 to 6 weeks period between the two cycles of treatment is recommended. In vaginitis caused by Trichomonas an association with oral treatment is recommended.

Packages containing 6 and 12 vaginal ovuli.